Early-onset Alzheimer disease: when is genetic testing appropriate?

Alzheimer Disease and Associated Disorders
Jill Goldman, Craig E Hou

Abstract

Alzheimer disease (AD) is a neurodegenerative disease that is currently not preventable or curable. Early-onset AD can be due to mutations in several autosomal dominant genes. Clinical testing is available for presenilin 1 (PS1), which is the most common of these genes. However, many practical and ethical issues must be considered before ordering this test for patients with early-onset AD. In this paper, we present a case that demonstrates the complexities of genetic testing for early-onset AD.

References

Apr 17, 1999·American Journal of Human Genetics·T D Bird
Jan 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M B LiddellM J Owen
Feb 24, 2001·Journal of the American Geriatrics Society
Jan 15, 2002·Genetic Testing·V B Penchaszadeh

❮ Previous
Next ❯

Citations

Mar 15, 2005·Biochemical Pharmacology·Lary C WalkerSam Gandy
Dec 10, 2013·European Journal of Pharmacology·Mai A Abd-El-FattahHala F Zaki
Mar 29, 2013·International Journal of Pharmaceutics·Maluta S MufamadiViness Pillay
Feb 15, 2005·Drug Discovery Today·Homer H PienA Gregory Sorensen
Oct 16, 2004·Optometry : Journal of the American Optometric Association·Paul B Freeman
Oct 29, 2011·Journal of the International Neuropsychological Society : JINS·Steven Paul WoodsRomola S Bucks
Apr 3, 2009·The American Journal of Clinical Nutrition·José M Ordovas
Nov 27, 2008·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Kimberly A Cappuzzo
Jun 26, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Liyong WuSerge Gauthier
Sep 3, 2005·American Journal of Alzheimer's Disease and Other Dementias·José L MolinuevoRafael Blesa
Apr 25, 2017·Journal of Alzheimer's Disease : JAD·John Noel M ViañaFrederic Gilbert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.